<DOC>
	<DOCNO>NCT02624271</DOCNO>
	<brief_summary>Despite decline incidence , gastric cancer ( GC ) remain second lead cause cancer death worldwide . In France , second digestive cancer 7,000 new case per year . It well demonstrate patient H. pylori infection , atrophic gastritis intestinal metaplasia , high risk develop GC . It therefore important detect pre-neoplastic lesion early stage improve patient prognosis . Thus , aim project investigate possible screen gastric precancerous lesion blood test ( GastroPanelÂ® ) France , patient oesophagogastroduodenoscopy ( EGD ) prescription .</brief_summary>
	<brief_title>Diagnosis Gastric Precancerous Lesions Blood Test GastroPanel Patients With Increased Gastric Cancer Risk</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>Patients undergo oesophagogastroduodenoscopy ( EGD ) accord usual care Patients increase risk gastric cancer ( least one follow criterion ) : age &gt; 50 year , family case gastric cancer , know precancerous lesion , Biermer disease , H. Pylori infection , genetic predisposition ( ex : Lynch syndrome ) , MALT lymphoma , dyspepsia . Subjects affiliated appropriate social security system Subjects know active cancer Pregnancy Patients receive protonpump inhibitor Conditions may interfere study objective accord investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>gastric precancerous lesion</keyword>
	<keyword>blood test</keyword>
</DOC>